全文获取类型
收费全文 | 38791篇 |
免费 | 3767篇 |
国内免费 | 1067篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 827篇 |
妇产科学 | 306篇 |
基础医学 | 2246篇 |
口腔科学 | 196篇 |
临床医学 | 6526篇 |
内科学 | 11076篇 |
皮肤病学 | 621篇 |
神经病学 | 1209篇 |
特种医学 | 1492篇 |
外国民族医学 | 4篇 |
外科学 | 3912篇 |
综合类 | 4165篇 |
现状与发展 | 3篇 |
一般理论 | 1篇 |
预防医学 | 1980篇 |
眼科学 | 224篇 |
药学 | 6469篇 |
81篇 | |
中国医学 | 1174篇 |
肿瘤学 | 1051篇 |
出版年
2024年 | 109篇 |
2023年 | 1077篇 |
2022年 | 1343篇 |
2021年 | 2229篇 |
2020年 | 2394篇 |
2019年 | 2135篇 |
2018年 | 1927篇 |
2017年 | 1572篇 |
2016年 | 1411篇 |
2015年 | 1520篇 |
2014年 | 2678篇 |
2013年 | 2927篇 |
2012年 | 1996篇 |
2011年 | 2155篇 |
2010年 | 1779篇 |
2009年 | 1640篇 |
2008年 | 1587篇 |
2007年 | 1547篇 |
2006年 | 1361篇 |
2005年 | 1203篇 |
2004年 | 1000篇 |
2003年 | 924篇 |
2002年 | 717篇 |
2001年 | 667篇 |
2000年 | 480篇 |
1999年 | 553篇 |
1998年 | 459篇 |
1997年 | 455篇 |
1996年 | 373篇 |
1995年 | 368篇 |
1994年 | 340篇 |
1993年 | 291篇 |
1992年 | 291篇 |
1991年 | 302篇 |
1990年 | 235篇 |
1989年 | 167篇 |
1988年 | 177篇 |
1987年 | 167篇 |
1986年 | 145篇 |
1985年 | 167篇 |
1984年 | 154篇 |
1983年 | 108篇 |
1982年 | 79篇 |
1981年 | 99篇 |
1980年 | 74篇 |
1979年 | 49篇 |
1978年 | 45篇 |
1977年 | 49篇 |
1976年 | 36篇 |
1975年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
Detection of Atrial Fibrillation by Implanted Devices with Wireless Data Transmission Capability 总被引:3,自引:0,他引:3
NIRAJ VARMA† BRUCE STAMBLER SUNG CHUN† 《Pacing and clinical electrophysiology : PACE》2005,28(S1):S133-S136
Remote telemetry may facilitate the management of implantable devices. We tested the reliability of a new automatic, wireless home monitoring (HM) system that archives data every 24 hours. We retrospectively analyzed archival data from 276 consecutive pacing system implants to define temporal atrial fibrillation (AF) patterns and associated ventricular rate. An "AF day" was defined by a >20%/24 hour mode switch (MS) duration, irrespective of the MS number. Management decisions resulting from transmissions were noted. A pilot study confirmed that 89% of 22,356 transmissions were successful, of which >90% were received in <5 minutes. Data integrity was 100% preserved. Overall, AF developed in 29 patients (10.5%), representing a total of 645 AF days (mean = 22.2 ± 29.6 AF, median = 9 days), over 12 ± 2 months of monitoring. AF was infrequent (50% of 24 hours. Ventricular rates during 645 AF days in 29 patients averaged 95.1 ± 9.9 beats/min (median = 94 beats/min). Ventricular rates were >80 beats/min in 25 ± 30 AF days (median = 11 days). HM enabled rapid anticoagulation decisions. In recipients of implantable devices, automatic wireless telemetry with HM was efficient and reliable. Its application may overcome some current challenges in AF management by early notification and precise measurement of both AF burden and ventricular rate during AF. 相似文献
82.
乳剂依托咪酯对心脏手术病人麻醉诱导期循环功能的影响 总被引:1,自引:0,他引:1
目的 本文应用乳剂依托咪酯,观察其对心脏手术病人麻醉诱导期的循环影响。方法 选择心脏手术病人80例,心功能Ⅲ~Ⅳ级,随机分为两组,每组2 0例:Ⅰ组(水剂组) :水剂依托咪酯0 2 5mg kg-1;Ⅱ组(乳剂组) :乳剂依托咪酯0 2 5mg kg-1。记录麻醉前、注射依托咪酯前、后,气管插管后1min和3min时段的各监测参数。观察不自主肌肉颤动,注射疼痛感及过敏反应等不良反应。结果 显示两种剂型的依托咪酯各时间点的SBP、DBP、MAP、HR各组间无显著差异(P >0 0 5 )。两组在注射依托咪酯后SBP、DBP、MAP、HR轻度下降,但与注射前均无统计学差异(P >0 0 5 )。不自主肌肉运动Ⅰ组8例、Ⅱ组6例:两组间无显著差异(P >0 0 5 )。静脉注射处疼痛Ⅰ组14例、Ⅱ组1例,两组间显著差异(P >0 0 5 )。结论 乳剂依托咪酯具有麻醉诱导平稳,心血管影响轻微,副作用少在应用上优于水剂依托咪酯,可用于高龄及心脏功能受损害患者的麻醉诱导。 相似文献
83.
目的探讨内源性热休克蛋白90(HSP90)在缺氧心肌细胞丝氨酸苏氨酸蛋白激酶(AKT)相关信号通路中的作用。方法建立新生Wistar大鼠心肌细胞缺氧模型,将细胞分为正常组、缺氧组、加入HSP90特异性阻断剂格尔德霉素后再缺氧组(格尔德霉素+缺氧组)。于缺氧后1、3、6、12、24、48h用噻唑蓝法检测心肌细胞的活力;缺氧24h,原位缺口末端标记法检测心肌细胞凋亡指数(AI);缺氧1、3、6、12、24h,蛋白质印迹法检测大鼠心肌细胞中内源性HSP90及AKT表达水平。结果(1)缺氧24、48h,缺氧组、格尔德霉素+缺氧组细胞活力均较正常组明显下降(P〈0.05);格尔德霉素+缺氧组细胞活力缺氧12h即开始明显下降,缺氧48h时明显低于缺氧组(P〈0.05)。(2)缺氧24h,缺氧组细胞AI为(10.7±1.2)%,明显高于正常组[(1.9±0.3)%.P〈0.05];格尔德霉素+缺氧组细胞AI为(26、3±5.3)%,明显高于缺氧组(P〈0.01)。(3)缺氧12h,缺氧组心肌细胞内源性HSP90及AKT表达水平高于正常组与格尔德霉素+缺氧组;缺氧24h,缺氧组有所下降.格尔德霉素+缺氧组则下降更明显。结论内源性HSP90对维持心肌细胞的活力有重要作用.缺氧心肌细胞AKT表达水平可受内源性HSP90表达水平的影响。 相似文献
84.
紫外线对晶状体上皮细胞损伤的研究进展 总被引:5,自引:0,他引:5
紫外线,特别是紫外线B,是老年性白内障的环境致病因素,晶状体上皮细胞生理状态的改变是白内障发生的早期表现。本综述总结了近年来国内外关于紫外线损伤对晶状体上皮细胞影响的研究,以及紫外线对晶状体上皮细胞的生物损伤效用和损伤机制。 相似文献
85.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
86.
Amit Dang MBBS Gaurav Garg Padmanabh V. Rataboli MD 《The International journal of eating disorders》2009,42(4):385-386
Nocturnal Sleep‐Related Eating Disorder (NSRED) is a well‐documented sleeping disorder where the person is reported to experience bizarre eating behavior during sleep. Although various causes are implicated in this disorder, role of drugs cannot be ruled out. Here we narrate an interesting rare case report of a drug‐induced new onset NSRED, where a 45‐year‐old man on zolipdem performed an unexpected and bizarre eating behavior during somnambulistic state, type of which has not been reported earlier in the literature. The case falls under even rarer category as such behavior in sleep is reported mainly in woman. © 2008 by Wiley Periodicals, Inc. Int J Eat Disord 2009 相似文献
87.
M C Post J G L M Luermans H W M Plokker W Budts 《Catheterization and cardiovascular interventions》2007,69(1):9-14
Migraine is a common neurological disorder with a great impact on the quality of life and social activities. The patent foramen ovale (PFO) is an intra-atrial right-to-left shunt with a prevalence of 25% in the general population. An increased prevalence is found in patients with migraine, especially in migraine with aura. Percutaneous PFO closure might decrease the prevalence of migraine. However, most of these observational studies were retrospective without a randomized design and the results need to be interpreted with caution. In this review we describe the association between PFO and migraine and the different pathophysiological hypotheses, which have been proposed to explain this relationship. 相似文献
88.
清开灵注射液治疗脑血管性痴呆32例 总被引:9,自引:0,他引:9
目的观察清开灵注射液治疗脑血管性痴呆的疗效.方法将中医学辨证属于实证的64例脑血管性痴呆患者随机分为治疗组(清开灵注射液组)和对照组(脑复康组),治疗5周后,将两组治疗前后在智力障碍程度、肢体功能、血液流变学指标、中医证型疗效方面的变化进行比较.结果经治疗后治疗组和对照组相比较,智力障碍程度变化(有效率、MMSE、ADL积分)、肌力、步行能力改变有显著性差异,p<0.05.而治疗前后组内及组间血流变指标虽有一定下降,但无统计学意义(p>0.05).结论清开灵注射液对脑血管性痴呆患者,在改善智力障碍、肌力、步行能力方面有较好的疗效. 相似文献
89.
Asystole Following Left Ventricular Pacing 总被引:1,自引:0,他引:1
During biventricular ICD implantation, pacing the epicardial inferior posterior-lateral surface of the left ventricle via the coronary sinus produced asystole. The proposed mechanism is a Bezold-Jarisch reflex manifested by a drop in heart rate and blood pressure through direct C fiber stimulation. (PACE 2004; 27[Pt. I]:815–817) 相似文献
90.
目的 观察免费板式组合药在DOTS中对合并乙肝的涂阳肺结核病人肝损害情况。方法 比较HBsAg、HBeAg、HBcAb阳性的涂阳肺结核病人与无乙肝的涂阳肺结核病人DOTS前后肝功能损害情况。结果 合并乙肝病人肝损害发生率66.3%,无乙肝者肝损害发生率8.6%,两者相比差异有显著性(P〈0.01)。22.5%病人因肝损害需更改治疗方案。结论 DOTS中合并乙肝的病人采用板式组合药用2H3R3Z3E3/4H3R3方案易发生肝损害,对这类病人应慎用常规方案,并要密切全程观察肝功能,尽可能应用肝损害较小的抗结核药。 相似文献